CONSIDERATIONS TO KNOW ABOUT LAS17

), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only when they have been independently inhibited, lending assistance into the proposal that a combination drug therapy focusing on these motors could be a workable system for overcoming chemo